Why ARRIVE should not thrive in Australia-Reference-Cited by-同舟云学术

Why ARRIVE should not thrive in Australia

Published:2018-10 Issue:5 Volume:31 Page:339-340
ISSN:1871-5192
Container-title:Women and Birth
language:en
Short-container-title:Women and Birth

Author:

Davies-Tuck Miranda,Wallace Euan M.,Homer Caroline S.E.

Publisher

Elsevier BV

Subject

Maternity and Midwifery,Obstetrics and Gynaecology

Reference17 articles.

1. Labor induction versus expectant management in low-risk nulliparous women;Grobman;N Engl J Med,2018

2. Practice advisory: clinical guidance for integration of the findings of the ARRIVE trial: labor induction versus expectant management in low-risk nulliparous women;ACOG,2018

3. Stillbirths: rates, risk factors, and acceleration towards 2030;Lawn;Lancet,2016

4. Stillbirths: recall to action in high-income countries;Flenady;Lancet,2016

5. Quarterly provisional estimates for infant mortality, 2015-quarter 3, 2017;Rossen,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Embodiment and the technologies of induction of labour;Midwifery;2024-11

2. Elective induction of labour at full‐term gestations and childhood school outcomes;Journal of Paediatrics and Child Health;2023-06-09

3. Trends in labor induction indications: A 20‐year population‐based study;Acta Obstetricia et Gynecologica Scandinavica;2022-09-16

4. The (After)life of a Trial: Biocommunicability of an At-Risk Pregnancy;Medical Anthropology;2022-08-01

5. Head in the sand: Contemporary Australian attitudes towards induction of labour;Australian and New Zealand Journal of Obstetrics and Gynaecology;2022-03-15